Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
19.99
-0.08 (-0.40%)
At close: Mar 9, 2026, 4:00 PM EDT
20.17
+0.18 (0.90%)
After-hours: Mar 9, 2026, 5:01 PM EDT
Apellis Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2,555 | 3,178 | 3,969 | 7,093 | 5,718 | 4,603 | |
| Market Cap Growth | -27.54% | -19.93% | -44.04% | 24.06% | 24.22% | 6.25% | |
| Enterprise Value | 2,562 | 3,173 | 4,036 | 6,737 | 5,123 | 4,385 | |
| Last Close Price | 19.99 | 25.12 | 31.91 | 59.86 | 51.71 | 47.28 | |
| PE Ratio | 115.95 | 141.97 | - | - | - | - | |
| PS Ratio | 2.55 | 3.17 | 5.08 | 17.89 | 75.81 | 69.15 | |
| PB Ratio | 6.84 | 8.59 | 17.37 | 36.47 | 33.66 | 23.17 | |
| P/TBV Ratio | 6.90 | 8.59 | 17.37 | 36.47 | 33.66 | 23.17 | |
| P/FCF Ratio | 56.77 | 70.61 | - | - | - | - | |
| P/OCF Ratio | 56.38 | 70.12 | - | - | - | - | |
| EV/Sales Ratio | 2.55 | 3.16 | 5.17 | 16.99 | 67.92 | 65.87 | |
| EV/EBITDA Ratio | 44.96 | 55.69 | - | - | - | - | |
| EV/EBIT Ratio | 46.22 | 57.26 | - | - | - | - | |
| EV/FCF Ratio | 56.91 | 70.50 | - | - | - | - | |
| Debt / Equity Ratio | 1.28 | 1.28 | 2.06 | 0.57 | 0.66 | 1.06 | |
| Debt / EBITDA Ratio | 7.03 | 7.03 | - | - | - | - | |
| Debt / FCF Ratio | 10.54 | 10.54 | - | - | - | - | |
| Net Debt / Equity Ratio | 0.02 | 0.02 | 0.24 | -1.26 | -2.62 | -2.47 | |
| Net Debt / EBITDA Ratio | 0.12 | 0.12 | -0.33 | 0.48 | 0.75 | 0.92 | |
| Net Debt / FCF Ratio | 0.15 | 0.15 | -0.61 | 0.41 | 0.87 | 0.87 | |
| Asset Turnover | 1.02 | 1.02 | 0.93 | 0.51 | 0.09 | 0.07 | |
| Inventory Turnover | 3.50 | 3.50 | 3.63 | 3.15 | 6.35 | - | |
| Quick Ratio | 2.59 | 2.59 | 3.71 | 2.34 | 3.56 | 5.93 | |
| Current Ratio | 3.14 | 3.14 | 4.25 | 3.10 | 4.29 | 6.25 | |
| Return on Equity (ROE) | 7.48% | 7.48% | -93.55% | -290.14% | -353.93% | -370.20% | |
| Return on Assets (ROA) | 3.53% | 3.53% | -12.32% | -41.73% | -45.27% | -36.39% | |
| Return on Invested Capital (ROIC) | 13.32% | 15.62% | -142.16% | - | - | - | |
| Return on Capital Employed (ROCE) | 7.40% | 7.40% | -23.60% | -95.60% | -100.30% | -71.50% | |
| Earnings Yield | 0.88% | 0.70% | -4.98% | -7.45% | -11.41% | -16.21% | |
| FCF Yield | 1.76% | 1.42% | -2.22% | -8.39% | -9.01% | -12.26% | |
| Buyback Yield / Dilution | -4.80% | -4.80% | -4.40% | -11.84% | -25.70% | -12.32% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.